The aim of this study was to evaluate the usefulness and specificity of urinary 1-hydroxypyrene (1-OHPu) as a biomarker of the exposure from urban pollution to polycyclic aromatic hydrocarbons (PAHs) among outdoor workers in a meta-analysis. Our metaanalysis was performed according to standard methods, and the results show that the concentrations of 1-OHPu tend to be higher in exposed workers than in unexposed workers (if we exclude two highly heterogeneous articles), in exposed non-smokers than in unexposed non-smokers and in exposed than in unexposed workers who were carriers of the CYP1A1 genotype and in those with the glutathione-S-transferase M1 ( À )genotype. These genotypes enhance the effect of exposure, particularly in non-smokers. Smoking reduces the differences between exposed and unexposed subjects. In conclusion, our results suggest that the use of the 1-OHPu biomarker appears to be reliable for studying occupational exposure to PAHs from urban pollution, as long as environmental and behavioural factors are considered.
INTRODUCTION
The Association between PAH and Health The direct, adverse effects, especially the carcinogenic effects, of polycyclic aromatic hydrocarbons (PAHs) on human health are well documented. The PAHs themselves are not carcinogenic, but some PAHs derivatives are carcinogenic when converted by the body to compounds that can be excreted. Therefore, the toxic effects of PAHs are secondary to their biotransformation. This process is principally driven by the action of mixed-function monooxygenase cytochrome P450 enzymes (CYP1A1, CYP1A2, CYP1B1 and CYP3A4). These phase I enzymes convert the PAHs into reactive epoxides. The detoxification of these highly reactive, mutagenic and carcinogenic compounds is reliant upon their combination with glutathione in a reaction catalysed by glutathione S-transferase class M (GSTM). For the enzymes CYP1A1 and GSTM1, genetic polymorphisms affecting their catalytic activity are known.
Generally, the following PAHs are considered to pose a high health risk: benzo (j) fluoranthene, benzo (b) fluoranthene, benzo (k) fluoranthene, benzo (a) pyrene and dibenzo (a, h) anthracene. 1 Orjuela et al. 2 documented a significant association between prenatal exposure to PAHs and increased numbers of chromosomal aberrations in cord blood samples in 48 newborns. Cardiac dysfunction, 3, 4 miscarriage 5 and male infertility 6 due to disruption of sperm DNA have all been linked to PAH exposure. Moreover, PAHs can block the proliferation and differentiation of AhR, a ligand-activated factor expressed by B lymphocytes, 7 causing neurotoxicity. 8 Sources of PAH in the Urban Environment and Behaviour PAHs are organic compounds composed of two or more benzene rings that may also have alkyl groups or short-cycle alkyl components. Humans are exposed to various PAHs, such as naphthalene, acenaphthylene, acenaphthene and fluorene, benzo (a) pyrene. 9, 10 Human PAH exposure develops from several sources:
Foods may become contaminated from the deposition of particulate air pollution (e.g. in grain, fruit and vegetables), the absorption of PAHs from contaminated soil (e.g. potatoes) or the absorption of PAHs from contaminated water (e.g. molluscs, seafood and fish); 11 grilled meat and mate (a beverage commonly consumed in South American countries) are also sources of PAHs. Other sources include ashes and stone materials from volcanic eruptions and forest fires. 9, [12] [13] [14] Emissions from the incomplete combustion of hydrocarbons and heating systems fuelled by diesel, coal or wood are also a source of PAHs. Emissions from industrial plants, such as coke oven plants, petroleum refining, industrial tar production, asphalting processes and the production of graphite electrodes, are other sources of PAHs. 9, 15, 16 The absorption of PAHs occurs via the skin and gastrointestinal system and by inhalation.
Exposure among Outdoor Workers
There are many different categories of workers who more than others are in direct contact with vehicular traffic because of their 1 work (traffic policemen, those employed in public transport, delivery service workers, roads staff maintenance, newsagents, filling-station attendants). Because of their very high exposure to airborne dusts, they are very often taken as a reference category for studies and research. 17, 18 The role of urinary 1-hydroxypyrene (1-OHPu) low exposure is still considered obscure.
In workers exposed to mixtures of pollutants, including PAHs, there is a higher frequency of skin, lung 3, 19 and bladder tumours. 20 The 1-OHPu, a metabolite of the aromatic polycyclic hydrocarbon pyrene (PYRH), 21 is considered the main biological biomarker currently available for measuring exposure to PAHs. 9, 22, 23 The reasons for its use in biological monitoring include the presence of pyrene at a high percentage in all mixtures of PAHs, availability of 1-OHPu and the correlations between external exposure to the PYRH and its metabolite OHPu.
In environmental exposure to PAHs from urban pollution, the excretion of 1-OHP is correlated with the concentration of the breathing fraction (PM10) and with the total amount of airborne particulate matter. The dermal exposure is modest, and it is difficult to predict because of variations in the amount of exposed skin 24 and variations in the amount of PAHs absorbed. Approximately 90% of pyrene is transformed by the human body into 1-OHP, which is excreted in the urine as glucuronide and/or sulphate, with a urinary half-life of 6-35 h and an average urinary half-life of 18 h. 17, [25] [26] [27] [28] Rubino et al. 29 noted a paradoxical association between the inhaled dose of pyrene by non-smokers exposed to urban airborne contamination and the daily urinary excretion of 1-OHP. This finding emphasises that the concentration of the metabolite in the urine is 10 to 50 times higher than the inhaled dose of the parent compound. It has been suggested that the excessive amount of OHP may derive from the slow release of pyrene, which accumulates and becomes chemically embedded in the carbon soot that is trapped in the lung alveoli of the subjects.
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The 3-hydroxybenzo (a) pyrene is a metabolite formed by the transformation of a parent compound, which is classified as carcinogenic. Therefore, it could be used as an indicator of exposure to carcinogenic PAHs; unfortunately, it is difficult to trace because only a small fraction is excreted in the urine. This metabolite is usually retrieved only in cases of massive exposure to PAHs. 16 Bouchard et al. 30 in rats exposed to a mixture of PAHs noted that the elimination of 1-OHP increases. Benzo (a) pyrene elicits a rapid (2-4 h after exposure) metabolic induction of pyrene by increasing its urinary excretion, and consequently the excretion of 1-OHP.
Other authors 22, 23 have documented a good correlation between total PAH concentrations and the quantity of pyrene in the air, as well as between atmospheric pyrene and 1-OHPu. According to these findings, 1-OHPu is considered an indicator of recent and overall exposure to PAHs.
Although it is a metabolite of a non-carcinogenic substance, some studies have shown that 1-OHP can indirectly evaluate the carcinogenic risk of a working population. In fact, in workers exposed to PAHs in coke ovens, it was estimated that the exposure to a concentration of coal particles equal to the threshold limit value proposed by ACGIH (0.2 mg/m 3 ) corresponds to 4.4 mg/ g creatinine of 1-OHP value. 31 This value is associated with a relative risk of 1.3 for lung cancer mortality. 22, 23 From the current literature, it is not clear whether 1-OHP is a harmful substance in itself or whether the adverse effects depend on the parent compound (i.e. pyrene or the PAHs). 29 According to Wang et al. 32 1-OHP and UVA are responsible for the phototoxicity and death of Jurkat T cells. Other authors, including Ekunwe et al. 33 observed that the experimental treatment of human keratinocytes with aminopyrene, pyrene and 1-OHP in the presence of UVA rays causes 70% to nearly 100% cell death.
The current understanding of 1-OHP is often conflicting, and there is still uncertainty about the real diagnostic value of this metabolite, as it relates to exposure to urban air pollution. However, 1-OHP is considered useful and well-established in the examination of the work environment. 22 Motivate the Inclusion of Polymorphism as Intervening Variable Recently, the scientific literature has focused on the relationship between CYP1A1-GSTM1 polymorphisms and cancer, and some studies have suggested that these polymorphisms influence the excretion of 1-OHP. The CYP1A1 gene is characterised by numerous polymorphisms, but two of these polymorphisms are important to the PAH biotransformation process: CYP1A1*2A and CYP1A1*2B-CYP1A1*2A polymorphism, according to the current nomenclature, resulting in a gene region 3 0 restriction site MspI, consisting of an m2 allelic variant, and CYP1A1*2B polymorphism, consisting of an amino-acid substitution ( IIe 462 Val) located in exon 7. 12 These variants have been thoroughly studied, particularly their role in the promotion of the mechanisms of carcinogenesis. 34, 35 Although the results of studies are conflicting, mainly because of the different prevalence of variants in Caucasian and Asiatic populations, they show a positive relationship between the polymorphic variants and the onset of cancer. 36 The allelic variant of the enzyme GSTM1 is represented by the complete deletion of the gene, which produces an enzyme with no catalytic activity. This deficiency was correlated with an increased relative risk of lung cancer. 12 Aim The 1-OHPu is an indicator that was studied in workers with high exposure, although, in case of very low exposures, studies are limited. As PAHs are suspected carcinogens, it is important to characterise occupational exposure, even at low doses such as those from urban pollution, and investigate the reliability of this biomarker in discriminating exposures at low doses.
The aim of our study is to evaluate the usefulness and specificity of measures of 1-OHPu when used to assess the exposure of urban pollution of outdoor workers to PAHs, and to control for various intervening variables, such as smoking, diet and genetic polymorphisms, related to the excretion of this metabolite. [37] [38] [39] The meta-analysis method was used to achieve our aims.
MATERIALS AND METHODS

Search Strategies
All papers published in scientific journals through December 2010 that described controlled studies evaluating 1-OHPu concentrations in workers with and without exposure to urban air pollution were included. No restrictions for language or type of publication were applied during this search. Papers suitable for inclusion were identified by a systematic search of MEDLINE, PubMed, BioMed Central, NIOSHTIC-2, TOXLINE, Embase, Scopus, Cochrane and the TRIP database. The search was performed using the following keywords and Boolean operators: Various categories of outdoor workers, such as traffic police officers, professional drivers, street vendors and ecological operators, were considered exposed cases. Indoor workers, such as municipal police officers who performed organisational and management tasks, administrative office staff, university students, church personnel and rural workers, were considered controls. Firefighters and road maintenance workers were not included in this study because they are only occasionally (rather than continuously) exposed to urban air pollution, and because they are exposed to other pollutants in their work.
To perform an accurate meta-analysis, we only considered the studies in which the correlation between the excretion of 1-OHPu and urban pollution was assessed, and in which smoking habits, diet and the presence of the CYP1A1 and GSTM1 genotypes were assessed. Polymorphisms were assessed because some authors identified them as factors that can influence the levels of 1-OHPu. 12, 40 Two independent reviewers assessed the quality of the included studies and checked the extracted data and validity criteria against the original published report. Data were collected on the participants, the pollutants, the controls and the potential effect modifiers, such as smoking, dietary habits and genetic polymorphisms. We assessed the quality of the study using the Cochrane collaboration methods 41 and used a number of criteria, including allocation to the case or the control groups (coded as adequate, unclear or inadequate), reported diet, smoking habits, the presence of genotypes coding for the CYP1A1 and GSTM1 enzymes, and considered time shift work (coded as yes or no). Articles considered inadequate were excluded.
The role of alcohol was not considered in our study, because no systematic data on the concentrations of 1-OHP were documented in relation to drinking habits.
Using this systematic search, we found 102 papers; of these papers, 24 articles met the inclusion criteria and only 16 contained useful data. Two articles presented the same data; thus, only one was included. Two articles documented data that were collected in two different seasons of the year; thus, these studies were presented two times in the analysis. 42, 43 The data were grouped according to the variable investigated.
Owing to the few studies of the individual alleles of the CYP1A1 genotype, we grouped all of the alleles of this genotype into a single analysis. The characteristics of the studies used in the meta-analysis are shown in Table1.
Data Analysis
Relevant data were entered into ''Comprehensive Meta-Analysis'' by Biostat, which is the software used for conducting meta-analyses. For each study, the core information, including the sample size, the mean values and the standard deviations of the respective outcome variables for both exposed and unexposed workers, were entered. When only the standard error of the mean (SEM) was given, we computed the standard deviation by multiplying the SEM by the square root of the number of observations upon which the mean value was based. All the outcome variables were continuous. Group comparisons were performed between exposed and unexposed workers and between smokers and non-smokers. The effect size (ES), which reflects the magnitude of the strength of the relationship between two variables, was the unit used in our meta-analysis. The ES is bounded to a confidence interval that reflects the precision with which the ES was estimated in our study. The confidence interval in our study corresponds to 95% of observations; the P-value is fixed at Po0.05.
The standardised mean difference (SMD) assesses the treatment effects (ES) on the outcomes measured in our meta-analysis. The SMD is the difference between the respective mean values divided by the common measure of dispersion, which was computed from the standard deviations of the two groups. The ESs for each study were pooled in a ''fixed-effects model'' and a ''random-effects model (REM)'', and the results of both analyses are presented. The fixed-effects model assumes a common exposure effect in the studies, and also that the observed deviations among studies are only due to sampling. In this case, studies were weighted according to the inverse variance of the ES. Under the REM, ESs are not assumed to be common to all studies, but to vary according to a normal distribution. To decide which model is more appropriate, the statistic heterogeneity is calculated; we used the inconsistency index (I 2 ) to measure heterogeneity. The I 2 describes the amount of inconsistency in the results between the trials in a meta-analysis. It represents the amount of variability due to heterogeneity rather than to case and is defined as
where Q is Cochran's heterogeneity statistic (computed by summing the squared deviations of each study estimate from the overall meta-analytic estimate), and d.f. is the degrees of freedom. Negative values of I 2 are set to zero so that the value of I 2 lies between 0% and 100%. A value of 0% indicates no observed heterogeneity, and higher values show increasing heterogeneity. When the I 2 was high (450%), the ES was calculated using the REM, a statistical method in which the confidence interval is influenced by selection bias and by variation of the studies included in the meta-analysis. In this case, the REM is preferred to other solutions because it provides larger confidence intervals than those provided by other methods, such as the FEM. When the I 2 was low (o50%), the ES was calculated using the FEM, a statistical method in which the confidence interval is influenced only by the variations among the studies.
Standard error is the square root of the variance of the effect, computed as the reciprocal of the sum of the weights.
SMD is the difference in non-standard means divided by the square root of the ratio of the sum of the variances of each group (exposed/ unexposed), each one multiplied by the number of members of the group minus one, and the sum of the number of members of the two groups minus two.
Z-value is the ratio between the SMD and the relative standard error. P-value is the probability that there is no mean difference between the population of the exposed and the population of the unexposed, out of which the samples compared were extracted; in other words, it is the probability that the mean difference found in the two samples, exposed and unexposed (representative of the populations from which they were extracted), is due to chance and not due to an actual influence of the risk factor on the outcome variable (the 1-OHP).
The lower limit is obtained by subtracting the product between the z-score of a 95% CI (z ¼ 1.96) and the standard error of the effect, to the SMD.
The upper limit is obtained by adding the product between the z-score of a 95% CI (z ¼ 1.96) and the standard error of the effect, to the SMD.
RESULTS
There was no statistically significant difference in the concentrations of 1-OHPu between the exposed and control group [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] (ES 0.30; 95% CI: À 0.01 to 0.62; P ¼ 0.064). The studies were very heterogeneous (I 2 ¼ 88%). Because of the high heterogeneity, two articles (Chetiyanukornkul et al. 50 and Ayi Fanou et al. 57 ), in which values differed considerably from the average of the other articles, were considered abnormal and were excluded from the analysis. An analysis of the remaining studies indicated that there was a modest but significantly higher concentration of 1-OHPu in the exposed group compared with the control group (ES 0.28; 95% CI: 0.08-0.49; Po0.008); however, although the heterogeneity decreased, it remained high (I 2 ¼ 70%) (Figures 1 and 2 ). In the articles in which smoking was considered, the concentrations of 1-OHPu in exposed and unexposed smokers were not significantly different [44] [45] [46] [47] [48] [49] (ES 0.20; 95% CI: À 0.22 to 0.61; P ¼ 0.358), and the I 2 value was 60%. In contrast, the concentrations of 1-OHPu in exposed and unexposed non-smokers were significantly different [44] [45] [46] [47] [48] [49] (ES 0.76; 95% CI: 0.39-1.12; Po0.001), with an I 2 of 53%. The exposed and unexposed non-smokers differed in their concentrations of excreted 1-OHPu of 0.187 mg/g creatinine (weighted mean of non-SMD) (Figures 3 and 4) .
The levels of 1-OHPu in exposed and unexposed carriers of a particular CYP1A1 genotype (CYP1A1 2A and/or CYP1A1 2B) were significantly different 44, 46, 47 To assess the efficacy of 1-OHPu as an indicator of exposure to PAHs and pyrene in groups exposed to low and high levels of traffic during the winter and summer Concentrations of some urinary metabolites of PAHs, including 1-OHP, were measured in exposed workers (garage mechanics and garbage collectors) and not exposed (office clerks).
The study was performed during the winter and the summer HPLC The urinary hydroxy metabolites of naphthalene, phenanthrene and pyrene showed low exposure to dieselderived PAHs; however, this exposure was higher in exposed workers than in the control group Hara et al. 49 To assess the applicability of 1-OHPu as an index of biological monitoring in the garbage collectors exposed to PAHs from traffic compared with a control group. Smoking variable was also studied (levels of urinary cotinine) 1-OHPu as a biomarker for exposure to air pollution Ciarrocca et al heterogeneity is low (I 2 ¼ 1%). There were significant differences in the concentrations of 1-OHPu in the exposed and unexposed carriers of the GSTM1-null genotype ( À ) 44, 46, 47 (ES 0.50; 95% CI: 0.19-0.78; Po0.002), with no heterogeneity (I 2 ¼ 0%). There was a significant difference in the effect of air pollution on 1-OHPu between the non-smokers and smokers with the GSTM1-null ( À ) genotype 44, 46 (ES 0.70; 95% CI 0.16-1. 21; Po0.02 vs ES 0.40; 95% CI À 0.11 to 0.91; P ¼ 0.126). In both cases, there was no heterogeneity (I 2 ¼ 0%). When cases with the GSTM1 ( þ ) genotype were considered, there was no significant difference between the exposed and unexposed subjects 44, 46, 47 (ES 0.6; 95% CI: À 0.12 to 1.32; P 0.104), and heterogeneity was high (82%). The concentrations of 1-OHPu in the exposed and unexposed non-smokers who were carriers of the GSTM1 ( þ ) genotype were not significantly different 44, 46 (ES 1.27; 95% CI: À 0. 13 to 2. 68; P ¼ 0.076) and showed high heterogeneity (I 2 ¼ 85%). The concentrations of 1-OHPu in the exposed and unexposed smokers who were carriers of the GSTM1 ( þ ) genotype were 1-OHPu as a biomarker for exposure to air pollution Ciarrocca et al not significantly different 44, 46 (ES 0.40; 95% CI: À 0.11 to 0.91; P ¼ 0.142). There was no heterogeneity (I 2 ¼ 0%). Table 2 describes the results of the analysis in detail.
DISCUSSION
The traditional biological indicator, included among those used in studies of exposure to PAHs, is the 1-OHPu, which is more reliable than other markers. 9, 22, 23, 29 Controlled studies on the use of 1-OHPu as a biological indicator of urban pollution exposure in occupationally exposed workers are limited and are characterised by a non-uniform assessment of occupational exposure. Several factors appear to be more important than environmental pollution in determining urine levels of 1-OHPu [44] [45] [46] [47] [48] 50, 58 . The results of our meta-analysis, which excluded two highly heterogeneous articles, suggest that concentrations of 1-OHPu tend to be higher in exposed subjects than in unexposed controls.
Smoke
The results of our study suggest that smoking is an important confounder, especially in the case of low occupational exposure to PAHs, such as exposure by urban pollution. In that case, exposure from smoking seems to result in a similar increase of OHPu like occupational exposure without smoking. It leads to non-distinctness of occupationally exposed and unexposed smokers. Consequently, it seems questionable whether exposure to urban pollution can be assessed in a reliable manner using the marker OHPu in study groups, including active (or passive) smokers. 14 The results of our study suggest that smoking reduces the differences in biomarker levels between occupationally exposed and unexposed workers.
Polymorphisms
Recently, the scientific literature has focused on the influence of genetic polymorphisms of two enzymes involved in the biotransformation of PAHs: CYP1A1 and GSTM1. 59 Levels of 1-OHPu in Figure 4 . Urinary 1-hydroxypyrene in total exposed and unexposed subjects. 1-OHPu as a biomarker for exposure to air pollution Ciarrocca et al exposed and unexposed workers were significantly different when the analysis was carried out in a controlled manner for the particular CYP1A1 genotype. Results for the GSTM1-null genotype carriers ( À ) resemble the trends for the CYP1A1 genotype.
Analytic Method
In our meta-analysis, there was no variation in the measurement of the biomarkers, as all of the studies used high-performance liquid chromatography (HPLC), a technique that can detect the smallest traces of PAHs but that lacks high specificity. This feature may compromise the accuracy when a substance is found in very low concentrations, as in urine. Some authors have suggested the use of HPLC/MS/MS (liquid chromatography coupled with a highperformance tandem mass spectrometry detector), which has been recently validated and which achieves the highest specificity in determining 1-OHP levels in urine samples with interfering substances. 60 The components of the evaluation are separated by HPLC and 1-OHP is determined with a fluorescence detector. The most comprehensive description of the method is that of Jongeneelen et al. 21 Descriptions of other adapted methods include Boos et al. 61 and Hansen et al. 62 Detection of 1-OHP in urine is a toxicological analysis of biological material for which a European interlaboratory comparison programme has been established. 63 The analytical conditions, the repeatability and the detection limits of the method used are sufficiently described in the articles; in some cases, these data were absent or present only in part. 64 
Heterogeneity
The high heterogeneity reflects the lack of a uniform method for defining external exposure.
The recruitment of groups that were not matched for age and sex or assessed for smoking habits or other sources of 1-OHP (including foods rich in PAHs and other environmental conditions) increased the variation.
The reasons for the high levels of heterogeneity we found may be related to the different methods used and to the low levels of exposure to urban air pollution, which give more value to confounding factors. To improve comparability among studies, these should be carried out on job categories appropriately stratified for potential confounders, on a large group of subjects, with the least possible heterogeneity of exposure and using the HPLC/MS/MS even though pretty expensive.
The high levels of heterogeneity reflect the need to standardise procedures for the selection of subjects and the sensitivity of 1-OHP measurements to variables other than environmental pollution. Thus, we believe that it necessary to establish standard criteria to avoid results ''contaminated'' by other sources of 1-OHP.
CONCLUSION
Environmental pollution by PAHs is derived from industrial plants, the combustion of coal for domestic heating and vehicular traffic; these variables affect people differently in different places. Therefore, the different sources of PAHs must be taken into consideration in the exclusion criteria for the identification of exposed and unexposed subjects. Our results indicate that we need a standardised protocol to identify and evaluate environmental and behavioural factors that influence the production of 1-OHP.
In future studies, it will be useful to determine the ''weight'' of individual factors in the formation and excretion of 1-OHPu. In addition, the influence of these factors on people living in different environmental conditions is also important.
Moreover, our results suggest that the use of the 1-OHPu biomarker appears to be reliable for studying occupational exposure to PAHs from urban pollution, as long as environmental and behavioural factors are considered. ABBREVIATIONS CYP, cytochrome P450; GST, glutathione S-transferase; 1-OHPu, urinary 1-hydroxypyrene; PAHs, polycyclic aromatic hydrocarbons; PYRH, hydrocarbon pyrene
FURTHER READING
The studies included in the meta-analysis are marked with an asterisk (*).
